Engerix-B hepatitis B vaccine (recombinant)/Smith, Kline & French.

Authors
Category Primary study
JournalGastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
Year 1991
Engerix-B [Hepatitis B Vaccine (Recombinant)], a product by SmithKline Biologicals, is a noninfectious recombinant DNA hepatitis B vaccine for immunization against infection caused by all known subtypes of hepatitis B virus. It provides a safe and well-tolerated vaccination regimen shown to confer immunity on the basis of anti-HBs antibody responses comparable with those of plasma-derived vaccines.
Epistemonikos ID: 509de6cefb91abdef2b579769eb028fceadf7b53
First added on: Nov 05, 2021